Epidermal growth factor receptor (EGFR) is central to epithelial cell physiology, and deregulated EGFR signaling has an important role in a variety of human carcinomas. Here we show that silencing of the EGF-related factor amphiregulin (AREG) markedly inhibits the expansion of human keratinocytes through mitotic failure and accumulation of cells with ⩾ 4n DNA content. RNA-sequencingbased transcriptome analysis revealed that tetracycline-mediated AREG silencing significantly altered the expression of 2331 genes, 623 of which were not normalized by treatment with EGF. Interestingly, genes irreversibly upregulated by suppression of AREG overlapped with genes involved in keratinocyte differentiation. Moreover, a significant proportion of the irreversibly downregulated genes featured upstream binding sites recognized by forkhead box protein M1 (FoxM1), a key transcription factor in the control of mitosis that is widely dysregulated in cancer. The downregulation of FoxM1 and its target genes preceded mitotic arrest. Constitutive expression of FoxM1 in AREG knockdown cells normalized cell proliferation, reduced the number of cells with ⩾ 4n DNA content and rescued expression of FoxM1 target genes. These results demonstrate that AREG controls G2/M progression and cytokinesis in keratinocytes via activation of a FoxM1-dependent transcriptional program, suggesting new avenues for treatment of epithelial cancer.
INTRODUCTION
Epidermal homeostasis requires balance between keratinocyte proliferation and differentiation; 1 however, the underlying regulatory network controlling this balance remains incompletely understood. 2 Epidermal growth factor receptor (EGFR) signaling is an important regulator of epidermal development and homeostasis [3] [4] [5] [6] and has an important role in the control of multiple keratinocyte functions including migration, 7, 8 proliferation, 9 differentiation, 10-12 survival 13, 14 and activation of innate and adaptive immune responses. [15] [16] [17] Deregulated EGFR signaling is a hallmark of epithelial cancer, 18 and EGFR is a validated target in several types of carcinomas. [19] [20] [21] [22] EGFR becomes activated in response to binding members of the EGF ligand family, 23 several of which are expressed in human keratinocytes and skin including amphiregulin (AREG), betacellulin, epigen, epiregulin, heparin-binding EGF-like growth factor (HB-EGF) and transforming growth factor-α (TGF-α). 7, 24, 25 Metalloproteinase-mediated cleavage of the transmembrane precursors of these growth factors is thought to be required for major EGFR ligand functions including cell proliferation and migration. 23 Different EGFR ligands mediate keratinocyte behavior in different cellular contexts. 7 AREG participates in embryonic morphogenesis of mammary gland and bone. 26, 27 It is the predominant autocrine growth factor for cultured keratinocytes, 7, 9, 28 and is markedly upregulated in hyperproliferative skin conditions including psoriasis and wound healing. 17, 29, 30 AREG is gaining increasing relevance in cancer research and treatment, as it is overexpressed in a wide variety of tumors, is a marker of poor prognosis and resistance to anti-EGFR therapies in a variety of epithelial neoplasms and it may confer tumor cells with autonomous growth. [31] [32] [33] [34] The mechanisms by which AREG regulates proliferation remain to be elucidated. We recently reported that short hairpin RNA (shRNA)-mediated silencing of the AREG gene markedly inhibits keratinocyte growth in a manner that cannot be reversed by the addition of EGF or other EGFR ligands. 9 Interestingly, AREG silencing results in the accumulation of flattened keratinocytes that are often binucleated. 9 In the present study, we set out to further elucidate the mechanism(s) by which proAREG controls keratinocyte proliferation and differentiation.
Using conditional AREG knockdown keratinocytes 9 in combination with high-throughput RNA sequencing (RNA-seq) and lentivirus-mediated gene expression, here we functionally implicate forkhead box protein M1 (FoxM1), a winged helix transcription factor, 35 as a key mediator of AREG's effects upon keratinocyte proliferation and differentiation. Because FoxM1 is a major regulator of G2/M progression, 36 which is widely overexpressed in human cancer and implicated in cancer progression and metastasis, 35 these findings have important mechanistic implications for the role of AREG in the pathogenesis and treatment of epithelial cancer. Figure 1 . AREG silencing profoundly alters keratinocyte morphology and cell cycle distribution in human keratinocytes. (a) Overview of the keratinocyte cell growth assay with and without 1 μg/ml Tet with and without 100 ng/ml rhAREG. (b) Parental N/TERT-TR-shAREG keratinocytes were subjected to growth assays and photographed at the end of the 6-day assay. Note that Tet-induced AREG silencing leads to the appearance of binucleated cells (arrows). (c) Quantification of cell numbers as assessed by flow cytometry-based cell counting using fluorescent reference beads. Data are expressed as cell numbers and represent 10% of the total cells per well. Data are mean ± s.e.m. (n = 4 with three biological replicates per experiment and condition). Significant pairwise contrasts (mean ratio; corrected P): control vs Tet (12.8; 0.0097), control vs Tet/AREG (12.2; 0.0051), AREG vs Tet (13.1; 0.011), AREG vs Tet/AREG (12.5; 0.0041). (d and e) CFSE-labeled keratinocytes were used in 6-day growth assays followed by DAPI labeling and analysis by flow cytometry. 'Day 0' denotes keratinocytes at the time of plating. Note that Tet-induced AREG silencing causes a marked decrease in cell division (~8-fold reduction relative to control keratinocytes, as assessed by CFSE dye dilution) (d) accompanied by a large increase in cells with ⩾ 4n DNA content (e) even in the presence of exogenous AREG.
silencing led to the appearance of flattened, binucleated cells that differed markedly in appearance from the 'cobblestone' morphology of these cells grown in the absence of Tet (Figure 1b ). Although addition of recombinant human (rh)AREG (or rhEGF or rhTGF-α, data not shown) had little or no effect in the absence of Tet (Figure 1b , upper panels), prominent cell enlargement was observed in its presence (lower panels). As assessed by flow cytometry-based cell counting ( Figure 1c ) and by carboxyfluorescein succinimidyl ester (CFSE) dye dilution (Figure 1d ), AREG silencing resulted in a 12.5-fold decrease in cell counts and an 8-fold reduction in proliferation, respectively, irrespective of the addition of 100 ng/ml exogenous rhAREG. Relative to logarithmicphase N/TERT-TR-shAREG keratinocytes grown in complete medium (Figure 1e , upper panel), 6-day growth under autocrine conditions led to a modest increase of cells with 44n DNA content in the absence of Tet (middle panels). However, addition of Tet caused a massive increase in cells with ⩾ 4n DNA content (lower panels). Notably, neither the decreased proliferation nor the number of cells with ⩾ 4n DNA content could be reversed by 100 ng/ml rhAREG. We confirmed that trypsinization generated single-cell suspensions by forward vs side scattering and by fluorescence microscopy (data not shown).
Using high-throughput complementary DNA sequencing (RNAseq), we next analyzed the effect of AREG knockdown on the transcriptome of N/TERT-TR-shAREG cells in the presence or absence of exogenous rhEGF. Tet-induced AREG knockdown was effective (5.4% of control), and, as expected, was not normalized by the addition of 20 ng/ml EGF to the Tet-treated cultures (6.2% of control). We evaluated 12 916 genes for differential expression, including only those genes with expression ⩾ 1 c.p.m. (count per million reads) that mapped to protein coding regions in at least three of the six samples involved in the comparison (Tet-treated vs control). Of these, a total of 2331 were identified as altered significantly by Tet (differentially expressed genes, or DEGs). Of these, 1271 DEGs were increased (fold change (FC) 42 Gene ontology (GO) analysis performed using the GOstats package 37 revealed that the set of genes whose expression was downregulated by Tet and not normalized by the addition of rhEGF was significantly enriched for biological processes of cell cycle regulation, chromosome segregation, DNA replication and DNA repair (Figure 2a, left panel) . In addition to the FOXM1 and MYBL2 genes encoding the cooperating transcription factors FoxM1 and B-Myb, 38 ,39 the 30 most significantly downregulated genes not normalized by EGF included several other genes involved in the regulation of mitosis, including KIF20A, AURKB, CENPF, BIRC5 and PLK1 35, 36, 40 ( Figure 2a , right panel). Consistent with these observations, the 1 kb upstream regions of genes downregulated by AREG silencing and not normalized by EGF were significantly (P = 2.75 × 10 − 8 ) enriched for binding sites recognized by FoxM1, a key transcription factor involved in the G2/M cell cycle checkpoint, 36 as well as for E2F transcription factors involved in cell cycle progression (Supplementary Figure S1) .
Genes whose expression was upregulated by Tet and not normalized by EGF were enriched for biological processes of homophilic cell adhesion (cadherins), nucleosome assembly (H2 histones) and immune response (C3, IFIT2, IFIT3) (Figure 2b ). Genes whose expression was increased by Tet treatment and normalized by EGF were enriched for biological processes of organismal development and metabolism (Supplementary Figure S2) , whereas genes that were reduced by Tet treatment and normalized by EGF were enriched for processes of immune response and regulation of cell communication (Supplementary Figure S3) . Notably, the DEGs engendered by AREG silencing (up-or downregulated, irrespective of normalization by EGF) overlapped significantly (P o 0.001 by Wilcoxon's rank-sum test, see Materials and Methods) with genes whose expression is altered in response to 6 h of Ca 2+ -mediated keratinocyte differentiation ( Figure 2c ) and in response to EGFR inhibitor treatment (Figure 2d) .
We confirmed the RNA-seq results for a subset of genes on the same samples by quantitative real-time-polymerase chain reaction (QRT-PCR) using prevalidated TaqMan assays (Figure 3) , revealing excellent agreement with the RNA-seq results shown in Figure 2 . These QRT-PCR data also confirm the lack of normalization for these genes by exogenous EGF.
To determine the temporal relationship between AREG silencing, downregulation of FOXM1 and its targets and the cellular response, we performed time-course experiments in the presence or absence of Tet. As depicted in Figure 4 , AREG mRNA was reduced by 480% after 12 h of Tet treatment, preceding the reduction of FOXM1 and target gene expression by 12-24 h. Averaging over all eight genes, mRNA levels showed a significant decreasing linear trend with increasing time of Tet treatment (corrected P = 0.025), accounting for 88% of the total variation in RNA levels. Reduction in AREG RNA levels was greater compared with that of the other seven assayed genes at all times; this difference averaged across time is nominally significant for all seven genes (P ⩽ 0.0044) and significant after correction for multiple testing (P ⩽ 0.040) for four of them (FOXM1, KIF20A, NEK2, PLK1). Expression of all tested genes was reduced by 475% after 48 h of treatment without any noticeable changes in keratinocyte morphology (Figure 4b ). However, we found a significant reduction in mitotic cell counts starting at 48 h of treatment, lagging the reduction in expression of FOXM1 and its target genes (Figure 4c ).
Because FoxM1 is known to regulate many genes whose products are involved in the G2/M transition and mitosis, 35 we asked whether overexpression of FoxM1 could rescue keratinocyte growth and FoxM1 target gene expression in response to AREG silencing. To this end, we transduced the parental AREG knockdown cell line with a constitutively expressed lentiviral expression construct encoding FoxM1 (FoxM1-rescue cells). After antibiotic selection, we compared expression of AREG and FoxM1 proteins in FoxM1-rescue cells to the parental cells. As shown by western blotting (Figure 5a ) and immunofluorescence (Figure 5b ), the localization of AREG protein expression and the reduction of AREG levels in response to Tet treatment was very similar in both cell lines. AREG immunoreactivity was primarily localized in the perinuclear area and on the cell membrane and was strongly reduced by Tet treatment. FoxM1 protein was detected in nuclear and cytoplasmic extracts by western blotting (Figure 5a ), but appeared to be concentrated in the nucleus as assessed by immunostaining ( Figure 5b ). As assessed by both techniques, Tet-induced AREG silencing abolished FoxM1 protein expression in the parental cell line. FoxM1 protein expression was increased in FoxM1-rescue cells compared with parental cells (Figures 5a and b) , as was FOXM1 mRNA (~3-fold vs parental cells, data not shown). Interestingly, Tet-induced AREG silencing reduced FoxM1 protein levels even in FoxM1-rescue cells, by 450% in the nuclear fraction ( Figure 5a ). Quantitation revealed that this reduction was because of a marked decrease in the proportion of cells with strong nuclear FoxM1 staining (23% vs 13% after 48 h of Tet treatment; Figure 5c ).
Next, we used the FoxM1-rescue cells in autocrine keratinocyte growth assays and compared them with parental cells as well a control cell line with Tet-inducible expression of an shRNA targeting enhanced green fluorescent protein (EGFP). In this series of experiments, and as observed previously, 9 shRNAmediated AREG knockdown led to a 490% reduction in keratinocyte cell number in parental cells, whether in the presence or absence of 100 ng/ml rhAREG (P = 0.00012 and P = 0.0096, respectively; Figure 6a ). Indicative of FoxM1 rescue of the growthinhibitory effects of Tet in this system, the growth of FoxM1-rescue cells was significantly greater compared with that of parental cells after AREG silencing, whether in the presence (P = 0.004) or in the absence (P = 0.029) of exogenous AREG ( Figure 6a ). As shown in Figure 6b , flow cytometric analysis of 4',6-diamidino-2-phenylindole (DAPI)-stained keratinocytes revealed that FoxM1 expression markedly reduced the accumulation of cells with ⩾ 4n DNA content in AREG-silenced cells (a representative example is shown in Figure 6b , and all experiments are quantitated in Figure 6c ). Very similar results were observed in the presence or in the absence of added AREG (Supplementary Figure S4) . In contrast, Tet-induced expression of a non-targeting shRNA against EGFP had no effect on cell numbers ( Figure 6a ) and cell cycle distribution (Supplementary Figure S5) , ruling out nonspecific effects of Tet on keratinocyte proliferation.
To determine whether expression of FoxM1 in AREG knockdown cells restores cell cycle-related gene expression, we performed QRT-PCR for FOXM1 and a subset of its target genes. As shown in Figure 7 , FoxM1 target gene expression was normalized after constitutive expression of FoxM1 in AREG knockdown cells.
DISCUSSION
Some but not all effects of AREG silencing can be reversed by EGFR ligands Recently, we reported that AREG silencing profoundly inhibits keratinocyte proliferation in a manner that could not be reversed by the addition of exogenous AREG or other EGF ligands, 9 arguing that AREG participates in the regulation of proliferation in a manner that is separate from the traditionally accepted role of binding of its extracellular domain to the EGF receptor. Similarly, in this study, we also found many DEGs whose expression could not be normalized by exogenous EGF, a result that would not be expected if soluble EGFR ligands were able to compensate completely for the lack of proAREG. We did however find many genes whose expression was normalized by rhEGF ( Supplementary Figures S2 and S3 ), demonstrating that that there are many robust cellular responses to soluble EGFR ligands. In this regard, we have previously shown that soluble EGF and AREG are capable of reversing the effects of AREG silencing on extracellularregulated kinase (ERK) phosphorylation but not on growth inhibition. 9 Effects of AREG silencing on cell cycle progression We found that many genes whose expression is downregulated by AREG silencing and not normalized by EGF are involved in the regulation of the cell cycle, notably with respect to mitosis, nuclear division and cell division (Figure 2a) . Many of these genes encode proteins known to be important for G2/M cell cycle progression and/or cytokinesis, 36 a finding consonant with the appearance of (Figure 1d) . Notably, many of these genes feature upstream binding sites recognized by FoxM1, including KIF20A,
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( Figure 2a and Supplementary Figure S1 ). FoxM1 is a winged helix transcription factor that regulates numerous genes whose products function during G2/M and cytokinesis. 35, 36 It also regulates molecular events related to cell proliferation at other stages of the cell cycle. 44 FoxM1 is overexpressed in hepatocellular, breast, head and neck, cervical and basal cell carcinomas [45] [46] [47] and has been functionally implicated in cancer progression and metastasis. 44, 48, 49 Owing to these properties, FoxM1 is currently attracting substantial interest as a potential target in cancer diagnosis and therapy. 50 The MYBL2 gene encoding B-Myb was also one of the most prominently downregulated transcripts whose expression could not be normalized by EGF (Figure 2a ). This would be consistent with recent studies showing recruitment of FoxM1 and B-Myb to a multiprotein complex known as MuvB, which promotes mitotic gene expression during the G2/M phase of the cell cycle. 38, 39 Members of the E2F transcription factor family also have key roles during G1/S transition and S phase, as E2F1 target genes encode proteins that are important for DNA synthesis and chromosomal replication. 51 Because AREG halts cell cycle progression at G2/M, its silencing also blocks the transition of keratinocytes to G1/S, thereby accounting for the strong enrichment for E2F binding sites we observed in our TF binding site analysis of genes irreversibly downregulated by AREG silencing (Supplementary Figure S1) . N/TERT-2G keratinocytes are defective in p16 INK4 (CDKN2A) signaling 52 and our RNA-seq data confirm that this gene is not expressed in N/TERT-2G-derived AREG knockdown cells in the presence or absence of Tet (data not shown). p16
INK4 inhibits cyclin-dependent kinases 4 and 6, preventing phosphorylation of retinoblastoma 1 and inhibiting progression from the G1 to S phase in the context of cellular senescence.
53 P16 INK4 signaling is also frequently impaired in cancers. 54 Given that AREG silencing stops the growth of N/TERT keratinocytes despite their defect in p16 INK4 signaling, our data suggest that the requirement for proAREG for G2/M transition and/or cytokinesis may provide a novel target for epithelially derived tumors in which the p16 INK4 -related senescence checkpoint has been lost.
It could be argued that the significant reduction in mitotic gene expression is simply an effect of, rather than the cause of, AREG shRNA-induced growth arrest. However, our time-course experiments show that downregulation of FoxM1 and several of its target genes follows the reduction of AREG transcripts (Figure 4a ) and precedes the reduction in mitotic keratinocytes (Figure 4c) . Even more important, we show that overexpression of FoxM1 in AREG knockdown cells significantly rescues keratinocyte proliferation (Figure 6a ), normalizes cell cycle parameters (Figures 6b and c) and restores the expression of FoxM1-dependent genes (Figure 7) . Although the molecular details remain to be elucidated, these findings support the hypothesis that AREG regulates keratinocyte proliferation and G2/M transition via an FoxM1-dependent transcriptional program.
Apart from transcriptional regulation, FoxM1 protein activity is regulated at many levels, including RNA stability, translation, protein stability and posttranslational modification. 38, 55, 56 FoxM1 protein is hardly detectable in quiescent cells and increases in the late G1 phase of the cell cycle, reaching maximal levels in the G2/M phase before returning to low levels after completion of cytokinesis. 35, 56, 57 Loss of FoxM1 expression in this context appears to be because of its degradation at mitotic exit in a Cdh1(FZR1/CDC20C)-dependent manner. 56 In FoxM1-rescue cells, which expressed considerably higher levels of FoxM1 protein ( Figure 5 ) and threefold more mRNA (data not shown) compared with their parental counterparts, we observed a marked decrease in FoxM1 protein after AREG silencing, whose magnitude (450% in the nuclear fraction) was much greater compared with the Tet-induced reduction in FOXM1 mRNA (~17%; Figure 7 ) after 48 h of Tet treatment. This decrease also exceeded what would have been expected because of the reduction of endogenous FoxM1 expression in parental cells (Figure 5a ). We found that this was because of a decrease in the percentage of strongly FoxM1-positive nuclei, rather than a homogeneous reduction in the amount of FoxM1 per cell (Figure 5c ). While the mechanistic basis for these observations remains to be determined, these data are strongly suggestive of a functional interaction between AREG and FoxM1 in the context of cell cycle regulation, potentially involving a role for AREG in maintaining FoxM1 protein stability.
Effects of AREG silencing on keratinocyte differentiation FoxM1 expression is high in actively proliferating cells and low in terminally differentiated tissues. 58 Moreover, we and others have found that AREG depletion can induce multiple markers of epithelial differentiation. 9, 25 Consistent with these observations, genes whose expression was upregulated by Tet-induced AREG silencing and not normalized by EGF were strongly enriched for biological processes related to differentiation (Figure 2b ). Keratinocyte differentiation is strongly influenced by extracellular calcium concentration 59 and inhibition of EGFR tyrosine kinase activity 60 and we found a significant overlap between DEGs in AREG-silenced keratinocytes and genes involved in calciummediated keratinocyte differentiation (Figure 2c) , as well as genes whose expression is altered by inhibition of EGFR tyrosine kinase activity (Figure 2d) . Indeed, over 90% of the experiments manifesting significant overlap with DEGs engendered by AREG silencing involved experimental manipulations, resulting in growth inhibition and/or promotion of differentiation, including inhibition of signal-transduction mechanisms such as ERK and p38 known to be tightly coupled to EGFR in keratinocytes; silencing of genes known to block differentiation of keratinocytes or overexpression of genes known to inhibit differentiation of keratinocytes; treatment with growth-inhibitory cytokines; and treatments such as mitomycin C and irradiation that are known to be toxic to keratinocytes (data not shown). As discussed earlier for other keratinocyte responses to soluble EGFR ligands 9 ( Supplementary Figures S2 and S3) , it is notable that exogenous rhAREG profoundly increases the size of flattened, differentiated keratinocytes after AREG silencing, despite being unable to overcome mitotic blockade (Figure 1b) .
Loss of FoxM1 expression leads to profound cell cycle defects, with cells that enter mitosis but fail to complete cell division, resulting in mitotic catastrophe and/or endoreplication. 61, 62 Overexpression of FoxM1 can restore mitotic spindle integrity. 63 In this regard, it is notable that mitotic blockage has also been implicated in the process of keratinocyte differentiation. Thus, keratinocytes continue to replicate their DNA without equivalent execution of cell division as they differentiate, resulting in the production of large cells with increased DNA content as cells progress through the suprabasal layers. 2, 64, 65 In addition, the inhibition of mitotic kinases such as CDK1, AURKB or PLK1 triggers polyploidization and differentiation of primary keratinocytes. 64, 65 These published results are very consistent with our findings that in addition to producing binucleated cells with ⩾ 4n DNA content (Figure 1) , AREG silencing leads to the accumulation of flattened keratinocytes that are strongly engaged in terminal differentiation (Figure 2 ). Whether the effects of AREG silencing on keratinocyte differentiation formally depend on the integrity of nuclear content requires further investigation.
Summary and model
In summary, our data show that AREG controls cell division in keratinocytes via activation of a FoxM1-dependent transcriptional program and that FoxM1 expression can rescue the G2/M-arrested state of AREG knockdown cells. Moreover, AREG silencing also promotes keratinocyte differentiation in a manner that may be dependent on the induction of genomic instability because of the loss of FoxM1. As shown here and elsewhere, 9 keratinocyte growth arrest after AREG silencing cannot be rescued by exogenous EGFR ligands. Moreover, we have recently shown that a construct expressing the transmembrane and cytoplasmic domains of AREG can rescue keratinocyte growth arrest after AREG silencing. 66 At the same time, several lines of evidence indicate that soluble, shed AREG (or other EGFR ligands) can profoundly influence keratinocyte differentiation (Figures 1b and 2c) .
Based on these observations, we propose a model by which traditional EGFR signaling activated by soluble ligands promotes ERK signaling eventuating in cyclin D1 phosphorylation of Rb, resulting in the activation of E2F family transcription factors and progression to the S phase, whereas the cytoplasmic domain of AREG may support a FoxM1-dependent program necessary for G2/M transition and cytokinesis (Figure 8) . Loss of AREG expression is envisioned to trigger keratinocyte differentiation, possibly due to loss of genomic integrity, even though soluble EGFR ligands from a variety of sources may support keratinocyte differentiation once this program has been initiated. If confirmed, this model may provide new strategies for halting the growth of epithelial cancer cells by promoting their differentiation, especially in tumors that have overcome G1/S arrest checkpoints and/or are resistant to current anti-EGFR therapies. 
MATERIALS AND METHODS
Cell lines and culture conditions
All keratinocyte cell lines in this study were derived from the immortalized but non-transformed keratinocyte line N/TERT-2G 52 by stable transfection with lentiviral expression constructs (see below). N/TERT-TR-shAREG and N/TERT-TR-shEGFP, two cell lines with Tet-inducible expression of shRNA targeting AREG and EGFP, respectively, have been described previously 9 and were grown in keratinocyte serum-free medium (Invitrogen) with 0.4 mM CaCl 2 in the presence of zeocin and blasticidin. 9 Human embryonic kidney cells (293FT; Invitrogen) were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and 500 μg/ml geneticin.
Library construction and RNA-seq Total RNA was isolated from subconfluent N/TERT-TR-shAREG keratinocytes treated for 60 h with and without 1 μg/ml Tet with and without 20 ng/ml EGF (Qiagen RNeasy Mini Kits; Qiagen, Valencia, CA, USA) and RNA quality and quantity were assessed using an Agilent Bioanalyzer (Santa Clara, CA, USA). Complementary DNA libraries were prepared from polyadenylated RNA, and libraries for high-throughput sequencing were prepared using the Illumina mRNA-Seq Kit according to the manufacturer's protocol (Illumina, San Diego, CA, USA). Libraries were sequenced one sample per lane in an 8-lane flow cell on the Illumina Genome Analyzer IIx (San Diego, CA, USA). Sequence reads were aligned to the reference genome (NCBI build 37) using Bowtie and splice junctions were identified using Tophat. 67, 68 Expression values were expressed as the number of reads per kilobase per million mapped reads (RPKM). One sample per sequencing lane sequencing generated on average 31 million reads, resulting in~2.4 Gb per sample. RNA-seq data has been deposited to Gene Expression Omnibus; accession number GSE70230. 
Analysis of DEGs
DEGs were performed using edgeR with dispersions estimated using the Cox-Reid method. 69 To control the FDR, raw P-values from this analysis were adjusted using the Benjamini-Hochberg method, 70 and genes were identified as differentially expressed in response to AREG silencing based upon an FC threshold of 2 (FC 42 or o0.5) between Tet-treated and -untreated cells, with an FDR-adjusted P-value of 0.05. We defined DEGs whose expression was not normalized by EGF as those with twofold altered expression in both Tet and Tet+ EGF-treated cells (FDR o0.05; relative to control). DEGs for which expression normalized following EGF addition were excluded from this set (Po 0.05; Tet vs Tet+ EGF). Conversely, we defined DEGs whose expression was normalized by EGF as those altered twofold in Tet-treated cells (FDR o 0.05; relative to control), with expression subsequently altered twofold in the direction of control cells following the addition of EGF (FDR o0.05; Tet vs Tet+ EGF). DEGs for which expression had not completely normalized were excluded from this set (Po0.05; control vs Tet+ EGF).
Functional annotation of transcriptome data
Functional annotation was performed using GO, 71 KEGG 72 and Reactome. 73 Significantly enriched GO and KEGG pathway terms were identified using the conditional hypergeometric test implemented in the GOstats package (function: hyperGTest). 37 Enriched reactome pathways were identified using the R ReactomePA package (function: enrichPathway). 74 To identify transcription factor binding sites enriched in 1 kb sequences upstream of DEGs, we used semiparametric generalized additive logistic models (GAM). 75 For all human genes, we scanned upstream regions for matches to a set of 1937 position weight matrix (PWM) motifs, which represent the empirically determined binding affinities of known human transcription factors and unconventional DNA-binding proteins. Methods used to aggregate and filter the complete set of 1937 motifs have been described previously. 76 Similarly, methods used to detect PWM-DNA matches have been described. 69, 76 After we identified PWM-DNA motif matches, generalized additive logistic models were used to identify those motifs significantly enriched in 1 kb upstream regions of DEGs. 75 To control the FDR for all 1937 motifs included in our analysis, raw P-values generated from GAM models were adjusted using the Benjamini-Hochberg method. 70 The specific FoxM1 motif (consensus: 5′-TGCAAA/TTTGCA-3′) identified as significantly enriched in sequences upstream of Tet-decreased genes (not normalized by EGF) was generated using a protein microarray assay and was obtained from the human protein-DNA interaction database. 77 Significance of overlap of DEGs with data sets involving treatment of keratinocytes with calcium and EGFR inhibitors was determined from a Wilcoxon's rank-sum test comparing DEGs to non-DEGs. Differential expression patterns in each experiment were quantified using signed log 10-transformed P-values, with positive values indicating increased expression and negative values indicating decreased expression. The ranksum test was then used to compare log10-transformed P-values between DEGs and non-DEGs. As a final step, a Benjamini-Hochberg P-value correction is applied to generated FDR-corrected P-values, accounting for the fact that the analyses was repeated with respect to many different experiments. 78 
Lentivirus-mediated gene expression
Complementary DNAs encoding FoxM1 were cloned into the lentiviral expression vectors pLVX-aAcGFP-N1 (Clontech, Mountain View, CA, USA) and used for lentivirus production in 293FT cells as described previously. 9 Stably transduced keratinocyte cell lines with constitutive expression of these constructs were generated by infecting the inducible AREG knockdown cell line N/TERT-TR-shAREG followed by antibiotic selection with 10 μg/ml puromycin as described previously. 
Keratinocyte growth assays
Keratinocytes were plated in six-well plates at 1000 cells per cm 2 in complete KSFM medium and allowed to grow for~2 days until they had formed colonies containing four to eight cells. The cells were then cultured for 6 days in basal KSFM (without adding EGF or bovine pituitary extract) in the presence or absence of Tet (1 μg/ml) with and without AREG (100 ng/ml). At the end of the growth assay, keratinocyte cultures were either stained with crystal violet and photographed or analyzed by flow cytometry as described below.
CFSE labeling
Subconfluent keratinocytes were trypsinized, centrifuged for 6 min at 200 g, washed with phosphate-buffered saline (PBS) and then incubated with CFSE for 5 min on ice. The cells were washed repeatedly and resuspended in KFSM, and then counted and plated at 1000 cells per cm 2 as described in 'keratinocyte cell growth assays' above. Aliquots of the CFSE-labeled cells at the time of plating were fixed and processed as described in flow cytometry analysis as described below.
Flow cytometry
Keratinocytes were dislodged by trypsinization and concentrated by centrifugation for 6 min at 400 g. After removal of the supernatants, cells were resuspended in PBS and fixed by the addition of 4.5 volumes of 75% ethanol at 4°C. After an additional centrifugation step as above, cells were washed with PBS and resuspended in PBS containing 0.1% Triton X-100 and 1 μg/ml of DAPI. After the addition of equal numbers of 7.7 μm Sphero AccuCount Fluorescent Particles (Spherotech, Lake Forest, IL, USA) to each of the cell suspensions, keratinocytes were analyzed for cell number and cell cycle distribution using an LSR2 flow cytometer (BD Bioscience, Franklin Lakes, NJ, USA).
Immunofluorescence
Parental and FoxM1 cells were plated on sterile coverslips at 5000 cells per cm 2 and cultured in KSFM until~20% confluent, followed by incubation in the presence or absence of Tet for 48 h. After two washes in PBS, cells were fixed in 4% paraformaldehyde and permeabilized by incubation in 0.5% Triton X-100/0.1% sodium citrate for 5 min at room temperature. Preblocking was carried out by incubation in PBS/5% goat serum for 1 h at room temperature. AREG and FoxM1 were visualized by staining with anti-AREG antibodies (Proteintech) and anti-FoxM1 antibodies (Santa Cruz Biotechnology), respectively, followed by incubation with biotinylated secondary goat anti-rabbit IgG antibodies (Vector Laboratories, Burlingame, CA, USA) and streptavidin-Alexa Fluor 594 conjugate (Invitrogen). Images were captured using an Axioskop fluorescence microscope (Carl Zeiss, Jena, Germany) equipped with 1.4 megapixel Jenoptic ProgRes CF Cool camera (Jenoptics, Jena, Germany). For quantitation of cells with strong nuclear FoxM1 staining, random microscopic fields were taken with equal exposure times at ×100 magnification. For this analysis, only those nuclei were counted that manifested bright fluorescence, with the cutoff defined by the nuclei that remained visible after electronically reducing image intensity by 50%.
Western blotting
Parental and FoxM1 cells were grown in keratinocyte serum-free medium to 20% confluence, followed by incubation in the presence or absence of 1 μg/ml TET for 60 h. Cells were washed with PBS, dislodged by trypsinization and pelleted by centrifugation (6 min at 500 g). Cell pellets were resuspended in cytoplasmic extraction reagent 1 (NE-PER Nuclear and Cytoplasmic Extraction Reagents; Thermo Scientific, Rockford, IL, USA) and processed for the isolation of nuclear and cytoplasmic proteins according to the manufacturer's instructions. Equal amounts of nuclear and cytoplasmic extracts were analyzed by western blotting as described previously. 28 Chemiluminescence imaging was performed using a C-Digit Blot Scanner (LI-COR, Lincoln, NE, USA).
Statistical analysis of cell culture experiments
Observations for outcome variables (cell counts and mRNA levels) were log 10 -transformed to normalize distributions and to ensure that tests for differences in logged means were equivalent to tests for nonzero logged ratios of the means. The latter effect was sought because ratios of assayed values were more consistent across experimental replications compared with their differences. To avoid pseudoreplication, 79, 80 all transformed measurements from technical and cell well replicates of an experimental unit were averaged before analysis. Because cell culture experiments were designed to study two or three factors simultaneously, two-and three-way mixed-design or repeated-measures analysis of variance was used to test for main effects of factors, interactions among factors and trends and pairwise contrasts among levels of a factor, following standard guidelines (cf. Figures 7.2 and 8 .6 of Maxwell and Delaney). 81 Lentiviral expression construct was treated as a between-subjects factor; all other independent variables (cell culture treatment, gene, time) were treated as within-subject factors. Unadjusted F-tests were used for omnibus testing of equality of the means for the between-subject construct factor, followed when appropriate by Dunnett's T3 post hoc test for all pairwise contrasts, which does not assume homogeneity of variance. The Greenhouse-Geisser epsilon-adjusted univariate test, which is robust to heterogeneity of pairwise treatment differences, was used for omnibus tests involving within-subject factors; post hoc pairwise comparisons of all within-subject factor levels were carried out using Bonferroni-corrected paired t-tests. For time, trend tests (linear, quadratic and cubic) were performed, as the levels of this within-subjects factor are naturally ordered. Correction of P-values for multiple testing was implemented to control the familywise error rate at α = 0.05 for each type of major effect (main and interaction) in each ANOVA; all reported P-values are two-sided. As designated in the figures, error bars are either ordinary s.e.m. or within-subject standard errors computed by Morey's correction 82 of Cousineau's alternative 83 to the method of Loftus and Masson. 84 
ABBREVIATIONS
AREG, amphiregulin; CFSE, carboxyfluorescein succinimidyl ester; DAPI, 4',6-diamidino-2-phenylindole; DEG, differentially expressed gene; EGF, epidermal growth factor; EGFP, enhanced green fluorescent protein; EGFR, EGF receptor; ERK, extracellular signal-regulated kinase; FoxM1, forkhead box protein M1; GF, growth factor; HB-EGF, heparin-binding EGF-like growth factor; QRT-PCR, quantitative real-time-polymerase chain reaction; Tet, tetracycline; TGF-α, transforming growth factor-α
